Pharma Journalist -

FDA Approves Alnylam’s AMVUTTRA for ATTR-CM

Mobile Insulin Dosing System

FDA Approves Alnylam’s AMVUTTRA for ATTR-CM

Servier and Black Diamond Strike Licensing Deal for BDTX-4933

Menarini Partners with VisualDx to Identify BPDCN

Novartis Gains FDA Approval for Fabhalta in C3G

Altesa BioSciences Announces Clearance of Investigational New Drug (IND) Application for Vapendavir

Oxford BioTherapeutics Partners with Roche on Cancer Targets

OPKO Health and Entera Bio Partner to Advance Oral GLP-1 Tablet for Obesity and Metabolic Disorders

Salipro Biotech and Boehringer Ingelheim Strike Research and License Deal to Boost Pipeline Programs

AstraZeneca Signs License Deal with Alteogen for Subcutaneous Oncology Formulations

AstraZeneca to Acquire EsoBiotec to Boost Cell Therapy Goals